To evaluate the clinical feature & pathology of atrophic rhinitis [AR] 75 cases of AR were evaluated retrospectively. Maximum cases were in the age group 20-30 years [40%].Male: female ratio was 1:1.5. Major symptoms were foul smell from nasal cavity along with crusting. The major signs found were atrophy of lateral nasal wall along with turbinates & nasal crusting. The most common organism found in nasal cavity & antrum were Pseudomonas aeruginosa followed by Klebsiella ozaenae. The present study describes the clinicopathological profile of 75 cases of atrophic rhinitis from 1.1.2011 to 31.12.2012 in the Dept. of ENT VSS Medical college Burla-Odisha. KEY WORDS: atrophic rhinitis INTRODUCTION: Atrophic rhinitis a chronic nasal disease characterised by progressive atrophy of mucosa & underlying bone of turbinates & form crusts which emit characteristic foul odour that is termed as ozaena. Although many of the pioneers have contributed handsomely to the entity of AR it still poses an intractable problem in rhinology which has been baffling to the mankind from time immemorial. Although atrophic condition of the nose has been known to the most ancient physicians from the days of Hippocrates, the term ozaena was coined by Claudius Galenus. A similar nomenclature to ozaena is found in ayurvedic literature as peenash. The disease is characterised by nasal obstruction due to crusts, roomy nasal cavity & foul smell emanating from nasal cavity of the patient.This study is a retrospective one done by selecting 75 cases of AR who were admitted & regularly followed up in the Dept. of ENT VSS Medical College Burla from 01.01.2011 to 31.12.2012. The aim of present work is to study the clinicopathological aspects of atrophic rhinitis. MATERIAL & METHODS:The study was carried out from 01. 01.2011 to 31.12.2012 Out of all cases of AR who were admitted in our department in the said period, 75 cases were selected randomly for study & their case records were evaluated. HP study of nasal mucosa, X-ray PNS (water's view) & antral puncture had been done in every case. The aspirated pus from antral puncture or the fluid aspirated after instillation of 2cc of luke warm sterile saline in the antrum had been sent for culture & sensitivity study. All above reports were evaluated.
BACKGROUNDThe facial nerve paralysis is a broad term having so many differential diagnoses starting from congenital causes to malignant tumour. Accurate diagnosis with localisation of the site of injury or compression and timely intervention has become a challenge to an otorhinolaryngologist. Objective-To outline the incidence of the different aetiologies and the profile of peripheral facial nerve paralysis patients in the Otolaryngology Dept. of ENT in VIMSAR, Burla. MATERIALS AND METHODSThe records of 53 patients with facial nerve paralysis seen during the years of 2016 & 2017 were analysed. RESULTSFrom the 53 patients analysed, 60.4% were male, maximum cases 35.85% were in 3 rd decade of age and had the right side of the face involved in 62.26%. Bell´s palsy was the most frequent aetiology (66.04%), others are traumatic (11.32%), Ramsay Hunt syndrome (1.89%), CSOM (16.98%), malignant otitis externa (1.89%). One case of Bell´s palsy during pregnancy was also seen in this series. CONCLUSIONThe data found are similar to the most of the literature showing that Bell´s palsy is still the most frequent. Males are more commonly affected with a preponderance to involve right side of face.
BACKGROUNDBurning mouth syndrome (BMS) is a syndrome with intra oral burning sensation without clinical cause which occurs daily for more than 2 hours per day persisting for more than 3 months, which may be associated with taste alteration and oral dryness. The etiopathogenesis of BMS remains elusive and the most accepted theory suggests a neuropathic pain condition involved with neurotransmitter GABA in the gustatory system. Clonazepam-GABA agonist has been used in clinical practices for BMS. Nortriptyline, a TCA inhibits the reuptake of serotonin and norepinephrine into the synapse, thereby enhancing signalling via these neurotransmitters and thus used in neuropathic pain of BMS.METHODS 72 patients of VIMSAR ENT OPD complained of burning mouth sensation without any oral or general pathology and diagnosed as BMS from September 2017 to February 2019 were included in the study. 36 patients were prescribed clonazepam and other 36 patients were treated with nortriptyline. Clinical evaluation after 6 wks. and 3 months of treatment was done and pain evaluated with verbal numerical scale (VNS). RESULTSOut of 72 patients, 46 were males and the mean age of presentation was 66 years. At the time of presentation, the mean baseline VNS score for the group (n=36) treated with clonazepam was 7.1 ± 0.9 and for the group (n=36) treated with nortriptyline was 6.8 ± 1.2. After treatment, VNS scores were 4.7 ± 1.3 and 4.5 ± 0.9 respectively at 6 weeks (p=0.510) and 3.3 ± 1.3 and 2.5 ± 0.9 respectively at the end of 3 months (p=0.499). CONCLUSIONSNortriptyline is a better drug than Clonazepam for management of pain in patients with BMS. BACKGROUNDBurning mouth syndrome (BMS) is an idiopathic condition characterised by abnormal burning sensation of oral cavity involving buccal mucosa, tongue mucosa and soft palate without any evident pathological changes and sometimes associated with oral dryness and odynophagia. It usually occurs daily for few minutes to hours in a day and may persist for more than three months. Synonyms of BMS are stomatodynia, glossodynia, dry mouth, sore mouth or glossopyrosis. Its aetiology has still remained unclear. Patton et al. suggested that in a large percentage of patients, BMS probably involves interactions among local, systemic, and psychogenic factors. 1 It is a neuropathic pain which may be due to some local causes like chronic irritation of gustatory system which mediate the secretion of GABA, due to systemic causes or it may be due to psychological factors which mediate the secretion of serotonin. According to many recent literatures BMS has a neuropathic aetiology. 2-5 BMS aetiology could be due to local factors such as composition of saliva, mucosal blood flow, inflammation, and changes in cell morphology. [6][7][8][9] According to Lamey and Lewis BMS is of three different types. BMS type 1:Burning increasing throughout the day and reaching its peak in the evening. BMS type 2: Characterized by the complaint of continuous sensory disturbances.
Head & neck region is the most common site of neurogenic tumors like neurofibroma. Mostly they are multiple & associated with NF-2 syndrome. Solitary neurofibroma involving nose & paranasal sinuses are very rare. Here, we present a rare case report of solitary neurofibroma present over nasal vestibule of an 18 years aged old patient. If neurofibroma is present as a small solitary tumour, it is curable by adequate primary excision (Batsakis 1979). We discuss the clinical presentation, differential diagnosis, imaging characteristics and treatment of this rarely encountered lesion. This is important to consider such a rare variety of tumor in differential diagnosis of a unilateral soft tissue mass of nasal cavity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.